米德诺林在癌症,帕金森病和代谢功能障碍中的新兴作用
Madhur Kalyan1, Pankaj Kumar Singh2, Arpana Verma3
1Department of Biochemistry, Postgraduate Institute of Medical Education and Research, Chandigarh, India. mdhrkalyan@gmail.com.
Molecular biology reports
|October 13, 2025
概括
米德诺林蛋白影响基因调节和新陈代谢. 这篇评论详细介绍了它在癌症和帕金森病等疾病中的作用,强调了它作为治疗点的潜力.
科学领域:
- 分子生物学分子生物学
- 生物化学 生物化学
- 遗传学 是一个遗传学.
背景情况:
- 米德诺林是一种多功能蛋白质,涉及基因调节,新陈代谢和疾病.
- 它通过无素独立的蛋白质体降解来影响早期反应基因.
- 米德诺林与胰腺β细胞中的葡萄糖激酶相互作用,影响葡萄糖代谢.
研究的目的:
- 审查当前关于Midnolin功能的知识.
- 为了突出Midnolin在各种人类疾病中的作用.
- 确定米德诺林作为未来研究的潜在治疗点.
主要方法:
- 对Midnolin现有研究的文献综述.
- 分析米德诺林在细胞过程中的参与.
- 综合关于Midnolin与疾病相关的数据.
主要成果:
- 米德诺林调节基因表达并影响葡萄糖和脂质代谢.
- 它与非酒精性脂肪肝病,帕金森病和多种癌症有关.
- 米德诺林会影响线粒体功能和瘤生长.
结论:
- 米德诺林是一种关键蛋白质,在细胞过程中具有多种功能.
- 它的失调与人类显著的病理有关.
- 对Midnolin的机制的进一步研究可能会产生新的治疗策略.
相关概念视频
Parkinson's Disease: Treatment
983
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
983
Parkinson's Disease: Overview
1.8K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.8K
Neural Regulation
43.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.1K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
Brainstem
5.7K
The brainstem, located inferior to the brain and superior to the spinal cord, serves as a bridge between the cerebrum and the spinal cord. It plays a vital role in relaying information and controlling critical life functions. It comprises three primary regions: the midbrain, pons, and medulla oblongata.
The Midbrain
The midbrain is located beneath the diencephalon and connects the cerebrum with the lower parts of the brain. The cerebral peduncles are prominent midbrain structures that house the...
The Midbrain
The midbrain is located beneath the diencephalon and connects the cerebrum with the lower parts of the brain. The cerebral peduncles are prominent midbrain structures that house the...
5.7K

